DUTASTERIDE | DUTASTERIDE | ATC G04CB02 ATC G04CA52
GENITO 5-ALPHA-REDUCTASE INHIBITOR TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA (BPH) | ORAL | Cmax 6.4 NANOMOLAR Tmax 2.5 HOUR F 60 PERCENT VD 400 LITER PPB 99 PERCENT Cl 0.33 LITER / HOUR (EQN) HT 840 HOUR SOLUBILITY INSOLUBLE IN WATER | 5 ALPHA-REDUCTASE | 3-oxo-5-alpha-steroid 4-dehydrogenase 2 UNIPROT P31213 SRD5A2 -- 3-oxo-5-alpha-steroid 4-dehydrogenase 1 UNIPROT P18405 SRD5A1 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |